URELLE is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Meda Pharmaceuticals. The primary component is Hyoscyamine Sulfate; Methenamine; Methylene Blue; Phenyl Salicylate; Sodium Phosphate, Monobasic, Monohydrate.
Product ID | 0037-6321_3c4ac6f5-f382-4cf7-aa0d-87959fa0c705 |
NDC | 0037-6321 |
Product Type | Human Prescription Drug |
Proprietary Name | URELLE |
Generic Name | Hyoscyamine Sulfate, Methenamine, Methylene Blue, Phenyl Salicylate, And Sodium Phosphate, Monobasic, Monohydrate |
Dosage Form | Tablet |
Route of Administration | ORAL |
Marketing Start Date | 2015-01-12 |
Marketing Category | UNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER |
Labeler Name | Meda Pharmaceuticals |
Substance Name | HYOSCYAMINE SULFATE; METHENAMINE; METHYLENE BLUE; PHENYL SALICYLATE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE |
Active Ingredient Strength | 0 mg/1; mg/1; mg/1; mg/1; mg/1 |
Pharm Classes | Oxidation-Reduction Activity [MoA],Oxidation-Reduction Agent [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2015-01-12 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | Unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2015-01-12 |
Ingredient | Strength |
---|---|
HYOSCYAMINE SULFATE | .12 mg/1 |
SPL SET ID: | 1d80a11c-6f86-403b-85d4-32ec1924dbe9 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
![]() URELLE 85481729 4220875 Dead/Cancelled |
DSM IP Assets B.V. 2011-11-28 |
![]() URELLE 77860362 3806629 Live/Registered |
MEDA PHARMA S.A.R.L. 2009-10-29 |
![]() URELLE 76405748 2697669 Dead/Cancelled |
AZUR PHARMA INTERNATIONAL II LIMITED 2002-05-10 |